Key Highlights

  • Oxbridge Re (NASDAQ:OXBR) was indicated at USD 0.79 pre-market on Tuesday, November 10, 2026, down 11.74% from a calculated prior close of USD 0.90 on Monday, November 9.
  • Second quarter 2026 Revenue was USD 940 thousand against USD 664 thousand a year earlier, with Net Income of USD 176 thousand against a loss of USD 1,873 thousand, or USD 0.02 per share.
  • Cash was USD 4.11 million at June 30, 2026, with restricted cash of USD 3.691 million for the Cat Re token program and USD 12.02 million for the HCI 2026 program.
  • Shares outstanding were 8,101,374, so the calculated Equity value at USD 0.79 is about USD 6.4 million, below shareholders' equity of USD 6.586 million reported at June 30.

What Moved Oxbridge Re Pre-Market (-11.74%)

The screener shows Oxbridge Re at USD 0.79, down 11.74%, which implies a prior close near USD 0.90. A September quote page showed USD 1.45 and a Market Value of USD 11.80 million, so the stock has already lost roughly 45% since then on a simple comparison, though the two sources were not reconciled. Average 20-day Volume then was only 16,851 shares, so a few small orders can shift the price. The company's August 13, 2026 release reported total revenue of USD 1,564 thousand for the first half against USD 1,356 thousand, a combined ratio of 133.1% against 355.5%, and the launch of AI GridWorks, a Subsidiary planned to own and operate AI data centers. Book Value per share is calculated at about USD 0.81.

Rationale: No Catalyst Identified, and the Usual Drivers

No company release or filing dated November 9 or November 10, 2026 was found in published coverage, so the reason for the decline is not established. As general context, sub-USD 1 Nasdaq names often move on third quarter results timing, a Nasdaq minimum bid price notice, an equity or Warrant offering, token program news, or simple profit taking after a spike. Nasdaq normally requires a USD 1.00 minimum closing bid, and a price of USD 0.79 sits below it, which is a risk Factor rather than a reported event. The SurancePlus unit completed five private placements on Solana raising USD 7.1 million gross, and cumulative gross proceeds exceed USD 16 million, but those are not tied to today's move.

Valuation, Liquidity and Risks

Total Assets were USD 20.372 million and total liabilities USD 1.020 million at June 30, with mezzanine equity of USD 12.578 million and an accumulated Deficit of USD 31.936 million. Trailing 12-month revenue was about USD 2.79 million in the September data. Shares outstanding rose from 7,664,122 at December 31 to 8,101,374, a 5.7% increase, which shows the dilution pattern small issuers can follow. Pre-market trading is thin, spreads are wide, and a Reversal at the open is possible. The core Reinsurance book earned only USD 368 thousand of net premiums in the quarter, so results depend on fee income from the SurancePlus program, which contributed USD 501 thousand, and on new ventures. Nothing here suggests the move will continue, and a recovery is equally unconfirmed.

Where Things Stand

The pre-market decline in Oxbridge Re (NASDAQ:OXBR) is 11.74% to USD 0.79, and no catalyst was identified in published coverage. The last results, on August 13, 2026, showed a swing to profit and a cash build, yet the market value near USD 6.4 million is tiny, so small volume can move the quote. Investors should treat the move as liquidity driven until a filing says otherwise.